TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration

TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration

Oleh : Dr. apt. Bantari Wisynu KW, S.Farm., M.Biomed

Original Full Text :

We usually reply with 24 hours except for weekends. All emails are kept confidential and we do not span in any ways.

Thank you for contacting us :)

Enter a Name

Enter a valid Email

Message cannot be empty

X